Inotiv, Inc. filings document the regulatory record of an operating contract research organization with Discovery and Safety Assessment and Research Models and Services operations. Current reports furnish financial results and business updates, including segment-related discussion for nonclinical and analytical drug development services, research models, and related products.
Material-event filings also describe credit-agreement administration, including waivers tied to minimum liquidity covenants, Nasdaq listing-compliance notices, shareholder voting matters, and governance disclosures. The filings provide formal records of capital-structure obligations, operating results, risk-related events, and public-company compliance matters for NOTV common stock.
Inotiv, Inc. reported that on August 8, 2025 it discovered a cybersecurity incident in which a threat actor gained unauthorized access to and encrypted certain company systems. In response, Inotiv launched an investigation, engaged external cybersecurity specialists, restricted access to affected systems, and notified law enforcement.
The incident has disrupted parts of Inotiv’s business operations by limiting access to portions of its networks, internal data storage, and some internal business applications. The company has activated its business continuity plan, shifting some work to offline alternatives while it works to restore systems, though the timeline for full restoration is not yet known. The investigation is ongoing, and Inotiv states that the full scope, nature, and operational and financial impacts are not yet known, and it has not determined whether the incident is reasonably likely to have a material impact.